Physician profile
Benjamin Gough
NPI 1649632175
$3,563.37
in general payments reported to CMS, 2019-2025
20 companies · $274 in 2025
The $274 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.93 · 2020: $88.33 · 2021: $185 · 2022: $2,170 · 2023: $155 · 2024: $673 · 2025: $274.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $956 · Education: $146.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $955.68 |
| Education | $146.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,861.49 | 2022-2025 | |
| Abbvie INC. | $304.21 | 2021-2022 | |
| Axonics, INC. | $270.55 | 2023-2024 | Axonics |
| Medtronic, INC. | $252.13 | 2022-2025 | Signia, Ligasure |
| Lexington Medical, INC. | $212.96 | 2024 | Aeon Endostapler & Echelon Flex Powered Stapler |
| Takeda Pharmaceuticals U.S.A., INC. | $208.30 | 2021-2022 | |
| Pacira Pharmaceuticals Incorporated | $126.81 | 2023-2024 | Exparel |
| Edwards Lifesciences Corporation | $88.33 | 2020 | |
| Integra Lifesciences Corporation | $42.51 | 2022-2024 | Integra, Surgimend, Omnigraft |
| Avanos Medical | $36.25 | 2021-2022 | |
| Ethicon US, LLC | $18.14 | 2025 | Proximate |
| Csl Behring | $17.93 | 2019 | |
| Organon LLC | $17.64 | 2022 | |
| Heron Therapeutics, INC. | $17.21 | 2021 | |
| Merck Sharp & Dohme LLC | $16.93 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cumberland Pharmaceuticals, INC. | $16.86 | 2022 | |
| Thd America, INC. | $15.28 | 2023 | |
| Tela Bio, INC. | $14.61 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Braintree Laboratories, INC. | $13.79 | 2022 | |
| Endo Pharmaceuticals INC. | $11.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Gough listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.